Both AMG-510 and vemurafenib selectively and potently abolished the growth of the K-RasG12C- and BRAF-V600E-mutant cancer cell 3D spheroids, respectively, with basically no activity against other cancer cell spheroids (Figure 6C and Supplementary Figures 6F–I). Here, BRAF is linked to cancer.